The latest OHSU forecast for the COVID pandemic in Oregon holds promising news. Experts expect the number of people hospitalized will slowly decline over October and November.

Oregon Health & Science University has been on the forefront of using the genetic editing technique known as CRISPR for years. Now, it has successfully used CRISPR to edit the genes in patients with a rare eye disease. Mark Pennesi is a professor of ophthalmology at OHSU, and Carlene Knight is one of the patients who received this treatment.

In Portland, Oregon, the local hospital sponsor, Oregon Health & Science University (OHSU), pulled its support from the marathon.

OHSU pulls out as a sponsor of the 2021 Portland Marathon for health concerns.

COVID cases are being tracked back to the Pendleton Round-Up, cites previous comments from Bill Messer, M.D., Ph.D., urging caution.

A legal filing against OHSU alleges disability discrimination against a patient.

A 17-year-old high school football player receives treatment at Doernbecher Children’s Hospital for Ewing sarcoma, a tumor that forms from a cell in bone or soft tissue.

OHSU partners with OHA, the Oregon Department of Education and school districts across the state to provide free COVID-19 weekly screening for students in grades kindergarten through 12th grade.

Volunteers with Positive Charge PDX arrived at OHSU on Thursday with dozens of goodie bags to distribute to the health care workers.

COVID survivor Rick Barde, who was hospitalized for two months at OHSU, returns to thank those who saved his life: “I wasn’t anticipating pulling up and getting so emotional — but these people gave me my life back. They worked very hard.” He returned to OHSU with the group Positive Charge! PDX, which donated dozens of care packages for OHSU health care workers.